Report Highlights
This report aims to provide a comprehensive study of the global market for epilepsy monitoring devices. Current and historical market revenues can be estimated based on the product type, and end-user type. The report presents analysis of the market data from 2021 (base year), estimates from 2022, projections of CAGRs through 2027.
Report Includes
- 17 total tables
- An up-to-date overview and analysis of the global market for brain epilepsy monitoring devices
- Analyses of the global market trends, with historic revenue data for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Estimation of the actual market size and revenue forecast for epilepsy monitoring devices market in USD million values, and corresponding market share analysis by product type, end user, and region
- Identification of the major stakeholders and analysis of the competitive landscape based on recent market developments and segmental revenues
- Company profiles of the leading global participants, including Abbott Laboratories, BioSerenity, Advanced Brain Monitoring Inc. and Epilert
Report Scope
In this report, the market has been segmented based on product type, end user and geography. The report provides an overview of the global epilepsy monitoring devices market and analyzes market trends. Using 2021 as the base year, the report provides estimated market data for the forecast period of 2022 to 2027. Revenue forecasts for this period are segmented based on product type, end user and geography; market values have been estimated based on the total revenue of epilepsy monitoring devices manufacturers.
This report describes the different types of epilepsy monitoring devices and their current and historical market revenues. This report also categorizes the global epilepsy monitoring devices market based on the region (North America, Europe, Asia-Pacific, and the Rest of the World).
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market shares and rankings.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||||||||
| Base year market size | $505.8 million | ||||||||||||||||||
| Market size forecast | $637.8 million | ||||||||||||||||||
| Growth rate | CAGR of 4.7% for the forecast period of 2022-2027 | ||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||
| Segments covered | product type, end user and geography | ||||||||||||||||||
| Regions covered | North America, Asia-Pacific, Europe, Rest of the World (RoW) | ||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||
| Companies studied |
|
||||||||||||||||||
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Neurology Devices: Global Markets
The global market for neurology devices is estimated to increase from $23.7 billion in 2023 to reach $31.7 billion by 2028, at a compound annual growth rate (CAGR) of 6.0% from 2023 through 2028.
Patient Monitoring Devices: Global Markets
The global patient monitoring devices market should reach $42.7 billion by 2022 and more than $65.4 billion by 2027, with a compound annual growth rate (CAGR) of 8.9% during the forecast period of 2022-2027.
Global Nerve Monitoring Systems Market
The global market for nerve monitoring systems should grow from $1.2 billion in 2021 to $1.6 billion by 2026 with a compound annual growth rate (CAGR) of 6.0% for the period of 2021-2026.
Home Health Monitoring Device Industry: Global Markets
The global market for home health monitoring systems should grow from $12.3 billion in 2020 to reach $29.1 billion by 2025, at a compound annual growth rate (CAGR) of 18.8% during the period of 2020-2025.
Recent Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More